Recombinant Mouse ILT-3 protein (Fc Chimera)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Mouse ILT-3 protein (Fc Chimera) is a Mouse Fragment protein, in the 1 to 238 aa range, expressed in HEK 293 cells, with >95%, < 1 EU/µg endotoxin level, suitable for SDS-PAGE.
View Alternative Names
CD85k, Gp49b, Lilrb4a, Leukocyte immunoglobulin-like receptor subfamily B member 4A, Mast cell surface glycoprotein Gp49B
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Mouse ILT-3 protein (Fc Chimera) (AB277024)
SDS-PAGE analysis of ab277024
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ILT-3 acts as an inhibitory receptor that modulates immune responses. It is often linked with the control of T cell activation and the maintenance of immune tolerance. ILT-3 does not form part of a larger protein complex. Its inhibitory function helps in preventing overactivation of the immune system by modulating the signaling pathways necessary for immune response. This modulation occurs through ITIM (Immunoreceptor Tyrosine-based Inhibitory Motif) domains that recruit phosphatases helping in dephosphorylating key signaling proteins and aiding in downregulation of immune cell activities.
Pathways
The ILT-3 protein is involved in important immune regulatory pathways contributing significantly to the immune checkpoint pathway. It interacts with other immunoglobulin-like receptors and is known to influence pathways involving PD-1 (Programmed cell death protein 1) and CTLA-4 (Cytotoxic T-lymphocyte-associated protein 4). By affecting these pathways ILT-3 serves as a checkpoint that ensures immune homeostasis prevents excess inflammation and influences the balance between immune activation and suppression within the body.
Specifications
Form
Lyophilized
General info
Function
Inhibitory receptor involved in the down-regulation of the immune response (PubMed : 10026201, PubMed : 24935931). Receptor for FN1 (PubMed : 34089617). Receptor for integrin ITGAV/ITGB3 (PubMed : 11323698). Inhibits IgE-mediated mast cell activation, at least in part through interaction with ITGAV/ITGB3 (PubMed : 10026201, PubMed : 11323698, PubMed : 11457897, PubMed : 8855262). Also inhibits KITLG/SCF-mediated mast cell activation (PubMed : 12884301). Through interaction with ITGAV/ITGB3, inhibits antibody production by memory and marginal zone B cells, probably by suppressing their differentiation into plasma cells (PubMed : 24935931). Inhibits IFNG production by CD8 T cells, CD4 T cells and natural killer cells (PubMed : 12682239). Inhibits antigen presentation by dendritic cells to T cells, preventing T cell activation (PubMed : 18792399). Inhibits lipopolysaccharide-mediated neutrophil-dependent vascular injury (PubMed : 14557414). Suppresses the allergic inflammatory response by inhibiting infiltration of neutrophils and eosinophils and preventing mast cell degranulation (PubMed : 17761953). Inhibits lysis by natural killer cells (PubMed : 8977169).
Post-translational modifications
Tyrosine phosphorylated.
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com